Pharma giant Novartis makes Stanhope and Mitsui's White City Place new UK HQ


Joint venture partners Stanhope, Mitsui Fudosan and AIMCo have secured a landmark tenant for White City Place with global pharmaceutical giant Novartis having signed to make the west London campus its new UK headquarters.

Novartis will initially be taking 54,000 sq ft of space from March 2019, with the option to expand further to 65,000 sq ft come January 2020.

The JV partners signed Autolus to become the first major life sciences company to take space at White City Place in August this year and Novartis will also join fellow bio tech firm Synthace at the 1.9m sq ft business, innovation and life sciences district.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article

Registration includes the following benefits:

  • Access up to four FREE articles per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.

Registered users and subscribers SIGN IN here to continue